News and Trends 27 Jul 2015
Ablynx and MSD upgrade their €1.7Bn deal to gigantic €5.7Bn
Using camel antibodies as drugs, sounds crazy? Belgian Ablynx is exactly doing that and has been very successful so far. It's now moving to the next step. It already signed a…